ID   PP1RA_RAT               Reviewed;         872 AA.
AC   O55000; Q6MG09;
DT   15-MAR-2005, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-1998, sequence version 1.
DT   02-OCT-2024, entry version 158.
DE   RecName: Full=Serine/threonine-protein phosphatase 1 regulatory subunit 10;
DE   AltName: Full=MHC class I region proline-rich protein CAT53;
DE   AltName: Full=Phosphatase 1 nuclear targeting subunit;
DE            Short=Protein PNUTS;
GN   Name=Ppp1r10; Synonyms=Cat53, Pnuts;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION IN PPP1CA INHIBITION, INTERACTION WITH
RP   PPP1CA, TISSUE SPECIFICITY, AND SUBCELLULAR LOCATION.
RC   STRAIN=Sprague-Dawley; TISSUE=Hippocampus;
RX   PubMed=9461602; DOI=10.1074/jbc.273.7.4089;
RA   Allen P.B., Kwon Y.G., Nairn A.C., Greengard P.;
RT   "Isolation and characterization of PNUTS, a putative protein phosphatase 1
RT   nuclear targeting subunit.";
RL   J. Biol. Chem. 273:4089-4095(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Brown Norway;
RX   PubMed=15060004; DOI=10.1101/gr.1987704;
RA   Hurt P., Walter L., Sudbrak R., Klages S., Mueller I., Shiina T., Inoko H.,
RA   Lehrach H., Guenther E., Reinhardt R., Himmelbauer H.;
RT   "The genomic sequence and comparative analysis of the rat major
RT   histocompatibility complex.";
RL   Genome Res. 14:631-639(2004).
RN   [3]
RP   FUNCTION IN PPP1CA INHIBITION, IDENTIFICATION IN A COMPLEX WITH PPP1CA AND
RP   RNA HOMOPOLYMERS, PHOSPHORYLATION AT THR-398, MUTAGENESIS OF ARG-396;
RP   LYS-397; VAL-399; TRP-401 AND 445-GLU--LEU-450, DNA-BINDING, RNA-BINDING,
RP   TISSUE SPECIFICITY, AND SUBCELLULAR LOCATION.
RX   PubMed=12574161; DOI=10.1074/jbc.m209621200;
RA   Kim Y.M., Watanabe T., Allen P.B., Kim Y.M., Lee S.J., Greengard P.,
RA   Nairn A.C., Kwon Y.G.;
RT   "PNUTS, a protein phosphatase 1 (PP1) nuclear targeting subunit.
RT   Characterization of its PP1- and RNA-binding domains and regulation by
RT   phosphorylation.";
RL   J. Biol. Chem. 278:13819-13828(2003).
RN   [4]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-313; SER-382 AND SER-591, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: Scaffold protein which mediates the formation of the PTW/PP1
CC       phosphatase complex by providing a binding platform to each component
CC       of the complex. The PTW/PP1 phosphatase complex plays a role in the
CC       control of chromatin structure and cell cycle progression during the
CC       transition from mitosis into interphase. Mediates interaction of WDR82
CC       and PPP1CA. Inhibitor of PPP1CA and PPP1CC phosphatase activities. Has
CC       inhibitory activity on PPP1CA only when phosphorylated. Binds to mRNA,
CC       single-stranded DNA (ssDNA), poly(A) and poly(G) homopolymers.
CC       {ECO:0000269|PubMed:12574161, ECO:0000269|PubMed:9461602}.
CC   -!- SUBUNIT: Component of the PTW/PP1 phosphatase complex, composed of
CC       PPP1R10/PNUTS, TOX4, WDR82, and PPP1CA or PPP1CB or PPP1CC. Interacts
CC       with PPP1CC. Interacts with PPP1CA, WDR82 and TOX4 (By similarity).
CC       {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-ProRule:PRU00649}.
CC       Note=Found in discrete nucleoplasmic bodies and within nucleoli.
CC       Associates with chromatin during interphase, excluded from condensed
CC       chromosomes during early mitosis and is reloaded onto chromosomes at
CC       the late telophase (By similarity). {ECO:0000250}.
CC   -!- TISSUE SPECIFICITY: Expressed in testis, brain and intestine (at
CC       protein level). Highly expressed in testis.
CC       {ECO:0000269|PubMed:12574161, ECO:0000269|PubMed:9461602}.
CC   -!- PTM: Phosphorylated on Thr-398 by PKA within the region necessary for
CC       interaction with PPP1CA. {ECO:0000269|PubMed:12574161}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=CAE84038.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF040954; AAB96775.1; -; mRNA.
DR   EMBL; BX883048; CAE84038.1; ALT_SEQ; Genomic_DNA.
DR   RefSeq; NP_075240.1; NM_022951.2.
DR   PDB; 4MOY; X-ray; 2.20 A; B=393-433.
DR   PDB; 4MP0; X-ray; 2.10 A; B/D=394-433.
DR   PDB; 6VTI; NMR; -; A=1-148.
DR   PDB; 7LQT; NMR; -; A=1-148.
DR   PDBsum; 4MOY; -.
DR   PDBsum; 4MP0; -.
DR   PDBsum; 6VTI; -.
DR   PDBsum; 7LQT; -.
DR   AlphaFoldDB; O55000; -.
DR   BMRB; O55000; -.
DR   SMR; O55000; -.
DR   STRING; 10116.ENSRNOP00000072634; -.
DR   iPTMnet; O55000; -.
DR   PhosphoSitePlus; O55000; -.
DR   jPOST; O55000; -.
DR   PaxDb; 10116-ENSRNOP00000001053; -.
DR   Ensembl; ENSRNOT00000088836.3; ENSRNOP00000082809.1; ENSRNOG00000059268.3.
DR   Ensembl; ENSRNOT00065044797; ENSRNOP00065036692; ENSRNOG00065025983.
DR   GeneID; 65045; -.
DR   KEGG; rno:65045; -.
DR   UCSC; RGD:620079; rat.
DR   AGR; RGD:620079; -.
DR   CTD; 5514; -.
DR   RGD; 620079; Ppp1r10.
DR   eggNOG; ENOG502QQ2I; Eukaryota.
DR   GeneTree; ENSGT00940000159263; -.
DR   InParanoid; O55000; -.
DR   OMA; NGPPQIW; -.
DR   OrthoDB; 2919452at2759; -.
DR   PhylomeDB; O55000; -.
DR   EvolutionaryTrace; O55000; -.
DR   PRO; PR:O55000; -.
DR   Proteomes; UP000002494; Chromosome 20.
DR   GO; GO:0000785; C:chromatin; IDA:RGD.
DR   GO; GO:0000781; C:chromosome, telomeric region; ISO:RGD.
DR   GO; GO:0016604; C:nuclear body; IEA:Ensembl.
DR   GO; GO:0072357; C:PTW/PP1 phosphatase complex; ISS:UniProtKB.
DR   GO; GO:0003677; F:DNA binding; IEA:UniProtKB-KW.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0008157; F:protein phosphatase 1 binding; IDA:RGD.
DR   GO; GO:0004864; F:protein phosphatase inhibitor activity; IDA:RGD.
DR   GO; GO:0003723; F:RNA binding; IEA:UniProtKB-KW.
DR   GO; GO:0010667; P:negative regulation of cardiac muscle cell apoptotic process; ISO:RGD.
DR   GO; GO:1904290; P:negative regulation of mitotic DNA damage checkpoint; ISO:RGD.
DR   GO; GO:0032206; P:positive regulation of telomere maintenance; ISO:RGD.
DR   CDD; cd00183; TFIIS_I; 1.
DR   DisProt; DP01202; -.
DR   Gene3D; 1.20.930.10; Conserved domain common to transcription factors TFIIS, elongin A, CRSP70; 1.
DR   IDEAL; IID50266; -.
DR   InterPro; IPR003617; TFIIS/CRSP70_N_sub.
DR   InterPro; IPR035441; TFIIS/LEDGF_dom_sf.
DR   InterPro; IPR017923; TFIIS_N.
DR   InterPro; IPR000571; Znf_CCCH.
DR   InterPro; IPR036855; Znf_CCCH_sf.
DR   PANTHER; PTHR46557; SERINE/THREONINE-PROTEIN PHOSPHATASE 1 REGULATORY SUBUNIT 10-RELATED; 1.
DR   PANTHER; PTHR46557:SF1; SERINE_THREONINE-PROTEIN PHOSPHATASE 1 REGULATORY SUBUNIT 10; 1.
DR   Pfam; PF08711; Med26; 1.
DR   Pfam; PF00642; zf-CCCH; 1.
DR   SMART; SM00509; TFS2N; 1.
DR   SMART; SM00356; ZnF_C3H1; 1.
DR   SUPFAM; SSF90229; CCCH zinc finger; 1.
DR   SUPFAM; SSF47676; Conserved domain common to transcription factors TFIIS, elongin A, CRSP70; 1.
DR   PROSITE; PS51319; TFIIS_N; 1.
DR   PROSITE; PS50103; ZF_C3H1; 1.
PE   1: Evidence at protein level;
KW   3D-structure; DNA-binding; Isopeptide bond; Metal-binding; Methylation;
KW   Nucleus; Phosphoprotein; Protein phosphatase inhibitor; Reference proteome;
KW   RNA-binding; Ubl conjugation; Zinc; Zinc-finger.
FT   CHAIN           1..872
FT                   /note="Serine/threonine-protein phosphatase 1 regulatory
FT                   subunit 10"
FT                   /id="PRO_0000071515"
FT   DOMAIN          73..147
FT                   /note="TFIIS N-terminal"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00649"
FT   ZN_FING         838..866
FT                   /note="C3H1-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00723"
FT   REGION          1..348
FT                   /note="Interaction with TOX4"
FT                   /evidence="ECO:0000250"
FT   REGION          147..213
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          247..270
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          307..398
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          357..433
FT                   /note="Necessary for interaction with PPP1CA"
FT                   /evidence="ECO:0000269|PubMed:9461602"
FT   REGION          382..450
FT                   /note="Essential for PPP1CA inhibition"
FT   REGION          393..408
FT                   /note="Necessary for interaction with PPP1CC"
FT                   /evidence="ECO:0000250"
FT   REGION          418..619
FT                   /note="Interaction with WDR82"
FT                   /evidence="ECO:0000250"
FT   REGION          534..837
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOTIF           420..423
FT                   /note="PP1-binding motif"
FT   COMPBIAS        151..200
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        320..335
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        584..600
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        627..677
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        784..835
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         313
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         382
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         398
FT                   /note="Phosphothreonine; by PKA"
FT                   /evidence="ECO:0000269|PubMed:12574161"
FT   MOD_RES         545
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q96QC0"
FT   MOD_RES         591
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         665
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0000250|UniProtKB:Q96QC0"
FT   MOD_RES         693
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0000250|UniProtKB:Q96QC0"
FT   MOD_RES         737
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0000250|UniProtKB:Q80W00"
FT   CROSSLNK        179
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:Q96QC0"
FT   CROSSLNK        262
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:Q96QC0"
FT   MUTAGEN         396
FT                   /note="R->A: Does not abolish interaction with PPP1CA and
FT                   does not reduce PPP1CA inhibition."
FT                   /evidence="ECO:0000269|PubMed:12574161"
FT   MUTAGEN         397
FT                   /note="K->A: Does not abolish interaction with PPP1CA and
FT                   reduces a little PPP1CA inhibition."
FT                   /evidence="ECO:0000269|PubMed:12574161"
FT   MUTAGEN         399
FT                   /note="V->A: Reduces interaction with PPP1CA and reduces
FT                   strongly PPP1CA inhibition."
FT                   /evidence="ECO:0000269|PubMed:12574161"
FT   MUTAGEN         401
FT                   /note="W->A: Abolishes interaction with PPP1CA and PPP1CA
FT                   inhibition."
FT                   /evidence="ECO:0000269|PubMed:12574161"
FT   MUTAGEN         445..450
FT                   /note="Missing: Abolishes PPP1CA inhibition."
FT                   /evidence="ECO:0000269|PubMed:12574161"
FT   HELIX           9..14
FT                   /evidence="ECO:0007829|PDB:6VTI"
FT   HELIX           16..18
FT                   /evidence="ECO:0007829|PDB:6VTI"
FT   STRAND          21..27
FT                   /evidence="ECO:0007829|PDB:6VTI"
FT   HELIX           28..38
FT                   /evidence="ECO:0007829|PDB:6VTI"
FT   HELIX           44..56
FT                   /evidence="ECO:0007829|PDB:6VTI"
FT   HELIX           60..68
FT                   /evidence="ECO:0007829|PDB:6VTI"
FT   HELIX           71..84
FT                   /evidence="ECO:0007829|PDB:6VTI"
FT   HELIX           88..100
FT                   /evidence="ECO:0007829|PDB:6VTI"
FT   HELIX           105..111
FT                   /evidence="ECO:0007829|PDB:6VTI"
FT   HELIX           113..123
FT                   /evidence="ECO:0007829|PDB:6VTI"
FT   HELIX           127..146
FT                   /evidence="ECO:0007829|PDB:6VTI"
FT   HELIX           404..406
FT                   /evidence="ECO:0007829|PDB:4MP0"
FT   STRAND          407..413
FT                   /evidence="ECO:0007829|PDB:4MP0"
SQ   SEQUENCE   872 AA;  92828 MW;  23CC61B4B296E948 CRC64;
     MGSGPIDPKE LLKGLDSFLT RDGEVKSVDG IAKIFSLMKE ARKMVSRCTY LNIILQTRAP
     EVLVKFIDVG GYKLLNSWLT YSKTTNNIPL LQQILLTLQH LPLTVDHLKQ NNTAKLVKQL
     SKSSEDEELR KLASVLVSDW MAVIRSQSST QPAEKDKKKR KEEGKSRTTL PERPLTEVKA
     ETRAEEAPEK KKEKPKSLRT TAPSHAKFRS TGLELDTPSL VPVKKNSSTV VVSDKYNLKP
     IPLKRQSATA APGDAAPPAE KKYKPLNTTP NTTKEIKVKI IPPQPMEGLG FLDALNSAPV
     PGIKIKKKKK VLSPTAAKPS PFEGKTSTEP STAKPSSPEP AAPAEPMDTD RPGTPVPAVE
     VPELMDAASS EPGALDAKPV ESPGDPNQLT RKGRKRKTVT WPEEGKLREY FYFELDETER
     VNVNKIKDFG EAAKREILSD RHAFETARRL SHDNMEEKVP WVCPRPLVLP SPLVIPGSNS
     QERYIQAERE KGILQELFLN KESPHEPDPE PYEPIPPKLI PLDEECAMDE TPYVETLEPG
     GSGGSPDGAG GSKLPPVLAN LMGSMGAGKS PQGPGGGGIN VQEILTSIMG SPNNHPSEEL
     LKQPDYSDKL KQMLVPHGLL GPGPVANGFP PGGPGGPKGM QHFPPGPGGP MPGPHGGPGG
     PVGPRLLGPP PPSRGGDPFW DGPGDPMRGG PMRGGPGPGP GPYHRGRGGR GGNEPPPPPP
     FRGARGGRSG GGPPNGRGGP GGGGMVGGGG HRPHEGPGGS MGSGHRSHEG PGGSMGSGHR
     SHEGPGHGGP HGHRPHDVPS HRGHDHRGPP PHEHRGHDGH GGGGHRGHDG GHSHGGDMSN
     RPVCRHFMMK GNCRYENNCA FYHPGVNGPP LP
//
